Astrocyte-secreted thrombospondin-1 modulates synapse and spine defects in the fragile X mouse model by unknown
RESEARCH Open Access
Astrocyte-secreted thrombospondin-1
modulates synapse and spine defects in
the fragile X mouse model
Connie Cheng1,2, Sally K. M. Lau2 and Laurie C. Doering1,2*
Abstract
Astrocytes are key participants in various aspects of brain development and function, many of which are executed
via secreted proteins. Defects in astrocyte signaling are implicated in neurodevelopmental disorders characterized
by abnormal neural circuitry such as Fragile X syndrome (FXS). In animal models of FXS, the loss in expression of
the Fragile X mental retardation 1 protein (FMRP) from astrocytes is associated with delayed dendrite maturation
and improper synapse formation; however, the effect of astrocyte-derived factors on the development of neurons is
not known. Thrombospondin-1 (TSP-1) is an important astrocyte-secreted protein that is involved in the regulation
of spine development and synaptogenesis. In this study, we found that cultured astrocytes isolated from an Fmr1
knockout (Fmr1 KO) mouse model of FXS displayed a significant decrease in TSP-1 protein expression compared to
the wildtype (WT) astrocytes. Correspondingly, Fmr1 KO hippocampal neurons exhibited morphological deficits in
dendritic spines and alterations in excitatory synapse formation following long-term culture. All spine and synaptic
abnormalities were prevented in the presence of either astrocyte-conditioned media or a feeder layer derived from
FMRP-expressing astrocytes, or following the application of exogenous TSP-1. Importantly, this work demonstrates
the integral role of astrocyte-secreted signals in the establishment of neuronal communication and identifies
soluble TSP-1 as a potential therapeutic target for Fragile X syndrome.
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Introduction
Fragile X syndrome (FXS) is the most common form of in-
tellectual disability and is a leading cause of autism
spectrum disorders [1], affecting about 1/4000 males and
1/8000 females. The causative mutation for the majority of
cases is a trinucleotide CGG expansion in the promoter re-
gion of the fragile X mental retardation 1 gene (FMR1),
which induces transcriptional gene silencing and the loss
of the fragile X mental retardation 1 protein (FMRP).
FMRP is an RNA-binding protein that is highly involved in
binding and regulating the translation, transport and stabil-
ity of a subset of mRNAs to synapses [2, 3]. Fundamental
research on the Fmr1 knockout (KO) mouse has provided
promising insights into the cellular and molecular
underpinnings of the condition. A well-described charac-
teristic feature of FXS is the presence of “immature” den-
dritic spines [4, 5]. These dendritic spine abnormalities in
Fmr1 KO mice are most pronounced during development,
but also persist into adulthood [6]. As spines are thought
to be the site of functional changes that mediate memory
storage, an immature or otherwise aberrant morphology
could represent the critical effect of the FXS mutation that
underlies learning impairments.
The appropriate formation of neural connections is
vastly dependent on reciprocal neuronal and glial interac-
tions. Until recently, the majority of research into the func-
tion of FMRP, and the consequences of its absence, has
largely been focused on neurons. However, it is now known
that FMRP is also expressed in cells of the glial lineage
[7, 8]. The expression of FMRP is typically highest in astro-
cytes within the first week of birth and subsequently
declines to low or undetectable levels [8]. Based on these
findings, work in our laboratory investigated the role of
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astrocytes in the development of the abnormal neurobiol-
ogy of FXS. Using an astrocyte-neuron co-culture system,
hippocampal neurons showed developmental delays in
dendritic growth patterns and also in the expression of ex-
citatory synapses when interfaced with astrocytes lacking
FMRP [9, 10], suggesting that dysfunction in non-neuronal
cells may be a contributing factor into the pathogenesis of
FXS.
During development and in the mature brain, astrocytes
are known to provide signals that guide synapse formation
and neurite development [11–14]. Astrocytes can regulate
the stability, dynamics and maturation of dendritic spines
through the release of secreted factors [15, 16]. In particu-
lar, astrocyte-derived thrombospondins (TSPs) are large
extracellular matrix proteins (450 kDa) that have been iden-
tified as major contributors to astrocyte-regulated excita-
tory synapse formation [17]. The TSP family consists of
two subfamilies, A and B, according to their organization
and domain structure [18, 19]; A includes the trimeric
TSP-1 and TSP-2, while B includes the pentameric TSP-3,
TSP-4 and TSP-5 [20, 21]. Recently, the THBS1 gene,
which encodes the TSP-1 protein, has been identified as an
autism risk gene [22]. In the central nervous system (CNS),
TSP-1 is mostly enriched in glia and predominantly
expressed by developing astrocytes during early postnatal
development in the rodent cortex [23], which correlates
with the onset of synaptogenesis. TSP-1 regulates excitatory
synaptogenesis through the gabapentin receptor α2δ-1 [24,
25], and neuroligin-1 in hippocampal neurons [26]. Double
TSP-1 and −2 knockout mice show a reduced number of
excitatory synapses in the cortex [17] and display dendritic
spine irregularities [27]. Given that FMRP and TSP-1 are
both expressed in immature astrocytes and have been asso-
ciated with the timely development of synapses, there is
reason to believe that the early regulation of synaptogenesis
could be influenced by TSP-1.
Previously, our group has demonstrated that astrocytes
modulate neuronal development in FXS; however, it is
unknown whether the effects can be attributed to direct
physical astrocyte-neuron interactions and/or to the re-
lease of extrinsic synaptic cues derived from astrocytes
that are responsible for guiding development. Here, we
determined the role of astrocyte-secreted TSP-1 on neur-
onal maturation and synaptic development in FXS. To
explore the consequences of altered astrocyte signaling
during development, we optimized an indirect (non-con-
tact) astrocyte-neuron co-culture method with either
astrocyte-conditioned medium or an astrocyte feeder layer
to promote neuronal attachment and survival. Using this
experimental paradigm, our results showed abnormal spine
maturation and synapse development in normal hippocam-
pal neurons grown with conditioned media and a feeder
layer from FXS astrocytes. We also found that TSP-1 levels
were markedly reduced in FXS cultured astrocytes and
conditioned media. Further, the addition of TSP-1 to
FXS cultures prevented synaptic and spine alterations.
These findings provide insight into the significance of
astrocyte-derived cues during early developmental periods




The FMRP mouse colony was established from breeding
pairs of FVB.129P2(B6)-Fmr1tm1Cgr mice. The wildtype
(WT) and Fmr1 knockout (KO) mice were maintained as
individual strains and genotyped regularly. Both male and
female mice were used in the experiments. The mice used
for these experiments were housed and bred at the
McMaster University Central Animal Facility. All experi-
ments complied with the guidelines set out by the Canad-
ian Council on Animal Care and were approved by the
McMaster Animal Research Ethics Board.
Hippocampal neuron isolation
Hippocampal neurons were obtained from embryonic
day E15–17 (day of sperm plug counted as E1) WT and
Fmr1 KO animals. Hippocampal tissue was isolated from
at least six embryonic pups, digested with 2.5 % trypsin,
and triturated through a fire-polished glass Pasteur pipette.
The neurons were subsequently plated on poly-L-lysine
(1 mg/ml, Sigma) and laminin (0.1 mg/ml, Invitrogen)
coated glass coverslips in 24-multiwell plates immediately
after dissociation at a density of 20 000 cells per well in
Neural Growth Medium consisting of Neurobasal (NB)
(Invitrogen) enriched with 0.5 mM GlutaMAX (Invitro-
gen), and 2 % B-27 Supplement (Invitrogen). Neurons
remained in culture for 17 days in vitro (DIV) to allow for
the development and maturation of dendritic spines. Im-
munocytochemical studies subsequently ensued to identify
alterations in spine density, morphology and length, and
the formation of excitatory synapses.
Primary cortical astrocyte cultures
Cortical astrocytes were prepared from four WT or Fmr1
KO postnatal day 0 to day 2 (P0–P2) pups, as detailed pre-
viously by our laboratory [28]. Briefly, whole brains were
extracted and cortical tissue was dissected and incubated
with 2.5 % trypsin (Invitrogen) and 15 mg/mL DNase
(Roche) at 37 °C. Following successive mechanical tritur-
ation using a serological pipette, the cells were passed
through a 70 μm cell strainer (Fisher Scientific), dissociated
into a single-cell suspension, and re-suspended in 10 %
Glial Media (GM) comprised of Minimum Essential
Medium (MEM) (Invitrogen), 0.6 % glucose and 10 %
horse serum (Invitrogen). The astrocytes were seeded in a
T75 flask and maintained in culture for 7–12 days in a hu-
midified 5 % CO2, 95 % O2 incubator at 37 °C. Partial
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medium changes were performed every 2–3 days. Cultures
consisted of at least 95 % astrocytes as determined by glial
fibrillary acidic protein (GFAP) immunocytochemistry.
Preparation of astrocyte-conditioned medium (ACM)
After 4–5 days in culture and achieving 50–65 % con-
fluency, the monolayers of astrocytes were subjected to a
Neuronal Growth Media (NGM) switch. The cultures were
washed extensively with Neurobasal (Invitrogen) and the
media was replaced with NB/B-27 culture medium to gen-
erate the ACM. In preparation for conditioning, ACM was
harvested for 4 days and collected. The media was filtered
using a 0.22 μm syringe filter for the removal of cellular
debris and concentrated ten times by filtration through a
10 kDa molecular weight cut-off (MWCO) centrifuge con-
centrator (Satorius Stedim). ACM was stored at −80 °C
and used at a final concentration of 5×. Notably, this pro-
cedure closely follows that of Christopherson et al. [17]
used for the isolation of thrombospondins. The ACM was
spun at 5000 rpm for 5 min to remove cell debris prior to
protein quantification or plating with the neurons.
Astrocyte feeder layer
To evaluate astrocyte non-contact mediated influences on
morphological parameters, ThinCert™ cell culture inserts
from Greiner Bio-One were utilized and placed in 24-
multiwell plates to facilitate the growth of the cortical as-
trocytes. These culture inserts consist of a 0.4 μm porous,
PET membrane support that forms a two-compartment
system. In this set-up, cultures were co-cultivated with
neurons and astrocytes in physically separated compart-
ments to facilitate paracrine-signaling interactions involv-
ing diffusible astrocyte-secreted factors. For preparation of
the astrocyte feeder layers (AFL), confluent astrocyte
monolayer cultures were trypsinized with 0.05 % Trypsin-
EDTA to lift adherent cells and subsequently passaged.
The dissociated cells (9000 cells) were seeded into the cell
culture inserts (positioned above the bottom of the well)
and maintained in 10 % GM for 3 days. Media was
switched to Neural Growth Media (NGM) at least one day
before plating neurons. Subsequently, hippocampal neu-
rons supplemented with NGM were plated below the cell
culture inserts on the coverslips. NGM was replenished
every 3–4 days.
DiI neuronal labeling
Dendritic spines were identified using the well-characterized
fluorescent marker DiI (1,1′-dioctadecyl-3,3,3′,3′-tet-
ramethylindocarbocyanine perchlorate), as described by
Cheng et al. [29]. In brief, the neurons were fixed with 2 %
paraformaldehyde and stained with lipophilic DiI (Invitro-
gen). For the staining, 2–3 DiI crystals were applied to
each coverslip. A small amount of Dulbecco’s Phosphate
Buffered Saline (DPBS, Invitrogen) was dispensed to the
edge of the wells to prevent dehydration of the cells.
The neurons were stained for 10 min on an orbital
shaker and copiously washed with DPBS to remove all
crystals. The cells were incubated in DPBS overnight at
room temperature. The following day, the coverslips were
rinsed with dH2O, air-dried and mounted to slides with
Prolong Gold Anti-fade (with DAPI) fluorescent mounting
medium (Invitrogen). The cells were visualized 72 h from
the initial staining to allow for the complete migration of
the dye into the dendritic spines.
Confocal imaging
Visual imaging of dendritic spines was acquired using a
Zeiss 510 confocal laser-scanning microscope (LSM 510).
All images were taken using a 63×/1.2 water immersion
lens. A 543 nm Hene-1 Rhodamine laser was utilized to
visualize the fluorescence emitted by DiI with the filter
channel 3 BP560–615 nm. To view the specimen with
reflected fluorescent light, the reflector turret was pro-
grammed to position F set 15 in correlation to the Rhoda-
mine laser, and the single-track configuration was chosen.
We used 1024 × 1024 pixels for image size and set the
scan speed at a setting of 6. Scan direction and line aver-
aging were also adjusted to a setting of 6. The pinhole
diameter was configured to 1 Airy unit (124 μm). Series
stacks were collected from the bottom to the top covering
all dendrites and protrusions, with an optical slice thick-
ness of 0.5 to 1 μm. The resulting images (4–6) were then
reconstructed according to z-stack projections of the max-
imum intensity.
Dendritic spine analysis
ImageJ software (RSB, NIH) was used for viewing the
confocal images and for spine quantification. In order to
increase the magnification for a better view of the spines
without loss of image quality, the resolution of the stack
image was increased by a factor of 5 in the X and Y di-
rections with the plug-in Transform J Scale [30]. The
length of a spine was obtained by drawing a line from its
emerging point on the dendrite to the tip of its head.
Approximately, 25 neurons were selected at random per
condition across three coverslips from two batches of
cultures per group were used for quantitative analysis.
Secondary dendritic branches were selected for analysis.
Density, morphology and length of spines were scored in
dendritic segments 10 μm in length. Morphologically,
two populations of spines were identified: (1) ‘mature’
stubby/mushroom-like spines, which are small, rounded
spines with or without a short neck and (2) ‘immature’
filopodium-like spines, which are typically longer, thin
and lack a head. Two to three independent experiments
were performed. For each independent culture, 40–50
dendritic segments (10 μm in length) were selected and
evaluated for spine analysis.
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Immunocytochemistry
Following 17 DIV, hippocampal neurons were fixed with
ice-cold (−20 °C) acetone for 20 min and processed for
immunocytochemistry. Cells were washed three times in
PBS and permeabilized with 0.1 % Triton X-100, respect-
ively. Non-specific binding was blocked with 1 % bovine
serum albumin (BSA) with the appropriate normal ani-
mal serum for 30 min at room temperature (RT). Pri-
mary antibodies were applied to the coverslips and
incubated overnight at 4 °C. The second day, following
washes with PBS, secondary antibodies were incubated
with the cells for 3 h at RT. Lastly, the coverslips were
mounted on to slides with Prolong Gold Anti-fade fluor-
escent mounting medium (Invitrogen) containing DAPI
to stain for nuclei. The following antibodies, diluted in
PBS, were used: monoclonal synaptophysin (clone SVP-
38; 1:250; Sigma-Aldrich), mouse monoclonal postsynap-
tic density 95 (PSD-95) (clone 6G6-1C9; 1:200; Millipore
Bioscience Research Reagents), donkey anti-mouse Alex-
aFluor 594 (1:1500, Life Technologies), and goat anti-
rabbit FITC (1:100, Jackson ImmunoResearch).
Primary cortical astrocytes were also processed in a
similar manner to visualize the localization of TSP-1 at 7
DIV. The following antibodies were used to label the as-
trocytes: mouse monoclonal thrombospondin-1 (A6.1;
1:100; ThermoFisher Scientific), polyclonal rabbit anti-
GFAP (1:500, Dako), donkey anti-mouse AlexaFluor 594
(1:1500, Life Technologies), and goat anti-rabbit FITC
(1:100, Jackson ImmunoResearch).
Synaptic puncta analysis
Images were acquired using a Zeiss AxioImager.M2 at
40× magnification configured with the ApoTome.2 and
Zeiss Zen Blue image acquisition software. Synapses
were identified by the co-localization of the pre-(synap-
tophysin) and post-synaptic (PSD-95) puncta, using a
custom written plug-in for ImageJ. After selecting a
50 μm segment along the dendrite, the image was proc-
essed using the above plug-in. Briefly, low frequency
background from each channel (red and green) of the
image was removed with the rolling ball background
subtraction algorithm. Then, the puncta in each single-
channel was ‘masked’ by thresholding the image so that
only puncta remained above threshold. Puncta were then
identified in each channel by the “Puncta Analyzer” plug-
in for Image J. Co-localization of the puncta in each chan-
nel was identified when the distance between the centers
of the two puncta was less than the radius of the larger
puncta. The number of co-localized puncta was then re-
corded as synapses. Two to three independent experi-
ments were performed. Approximately 20–25 neurons
from at least two coverslips were analyzed per condition/
group. For each independent culture, 45–50 (50 μm long)
segments along the dendrites were evaluated for synaptic
protein co-localization. Multiple dendritic segments were
sampled within a given neuron. The PSD95/synaptophy-
sin-immunoreactive puncta along the dendrites in each
photomicrograph were counted manually and normalized
by dendrite length. The photography and analysis of im-
munoreactivity were conducted in an investigator-blinded
manner.
Measurements of TSP-1 expression and release
TSP-1 levels were determined in astrocyte cultures and
astrocyte-conditioned medium (ACM). Confluent astrocyte
cultures were incubated with 0.05 % Trypsin-EDTA for
5 min at 37 °C. Once cells were fully lifted, media with
serum was added to stop the digestion. The cells were cen-
trifuged at 250 g for 5 min, washed with ice-cold PBS, and
lysed with cell lysis buffer containing 50 mM Tris–HCl,
150 mM NaCl, 1 % Triton-X and 5 mM EDTA with prote-
ase inhibitors (Roche). The lysates were collected in Eppen-
dorf tubes, centrifuged at 12000 rpm in an Eppendorf
microcentrifuge for 20 min at 4 °C, and the supernatants
were used to determine the intracellular concentration of
TSP-1. Aliquots of ACM from the same cultures were also
processed to determine secreted, extracellular levels of
TSP-1. TSP-1 protein measurements were determined
using the Mouse Thrombospondin-1 ELISA kit (Biotang,
Inc) following the vendor’s instructions. Sample protein
content normalization was based on total protein concen-
tration, which was determined for each sample by Bradford
assay.
Thrombospondin-1 treatments
To assess the neuromodulatory effect of exogenous TSP-
1 on spine development, hippocampal neuronal cultures
derived from Fmr1 KO mice were treated with human
recombinant TSP-1 (R&D System) to stimulate spine
formation. Recombinant TSP-1 was added to the neur-
onal media one day after plating, and replenished every
3 days for 17 days. A dose concentration of 250 ng/ml
was used to restore TSP-1 levels [27]. Control cultures
were incubated with heat-inactivated TSP-1 (TSP1-HI,
100 °C for 5 min), or gabapentin (GBP; 32 μM) [24] to
inhibit astrocyte induced spine and synapse formation.
Statistics
Statistics were performed using GraphPad Prism 5.0.
Differences were detected using a Student’s t-test or
one-way analysis of variance (ANOVA). Following one-
way ANOVA, post hoc differences were resolved using
the Bonferroni correction. A p-value of <0.05 was con-
sidered significant. All values are expressed as mean ±
SEM; n = number of neurons (unless otherwise speci-
fied); N = number of experiments.
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Results
Fmr1 knockout neurons display dendritic spine and synaptic
abnormalities relative to their wildtype counterparts
Previous reports have established the critical role of as-
trocytes in FXS [9, 10]; however, the role of astrocytes in
regulating dendritic spine formation has not been eluci-
dated. To investigate morphological differences, we first
examined dendritic spine subtypes and length in dissoci-
ated hippocampal neuronal cultures labeled with DiI
from Fmr1 knockout (KO) and wildtype (WT) mice at
17 days in vitro (DIV). DiI is a fluorescent carbocyanine
membrane dye that effectively illuminates the cellular
architecture of neurons and individual processes, includ-
ing dendrites and spines [31]. The morphological ana-
lysis of the neurons was conducted at 17 DIV to provide
sufficient time for spine development and maturation,
and circumvent the loss of neuronal processes due to
the instability of long-term cultures. For simplicity, we
categorized both the stubby and mushroom-shaped (ma-
ture) spines as “stubby”, and thin and filopodium spines
as ‘filopodia-like’ (immature) spines. Dendritic spine
length of each individual dendritic spine was measured
from its point of insertion in the dendritic shaft to the
distal tip of the spine, while rotating the image in 3D.
Figure 1a shows representative images of neurons and
dendritic segments from Fmr1 KO and WT mice.
Consistent with findings from the literature, we found a
clear difference in dendritic spine length between WT and
Fmr1 KO hippocampal neurons. Fmr1 KO neurons dis-
played remarkably longer spines (~1.5 fold increase) relative
to their WTcounterparts at 17 DIV (Fig. 1b and c, p < 0.01).
The structural profiles of the spines also differed consider-
ably between the WT and Fmr1 KO hippocampal neurons.
Fmr1 KO neurons displayed a higher density of immature
thin/filopodia-like spines (Fig. 1d, p < 0.05), and a striking
decrease in the number of mature stubby subtypes com-
pared to WT hippocampal neurons (Fig. 1e, p < 0.05). The
increased prevalence of elongated spines, characteristic of
immature synapses, suggests that dendritic development is
delayed in the Fmr1 KO neurons. Notably, a slight decrease
in the overall spine density was observed in the Fmr1 KO
neurons; however, the differences were not statistically sig-
nificant (p > 0.05, Additional file 1: Figure S1).
Next, we sought to examine the role of FMRP in regu-
lating excitatory synapse formation. The establishment
of neural circuitry requires vast numbers of synapses to
be generated during a specific window of brain develop-
ment. We used immunocytochemistry with antibodies
directed at synaptophysin (a presynaptic protein that ex-
ists as part of the synaptic vesicle membrane) and PSD-
95 (a postsynaptic protein that forms part of the postsynap-
tic density) to identify synaptic protein aggregates in neu-
rons at 17 DIV. Synapses were detected using the “Puncta
Analyzer” plug-in for ImageJ. The co-localization of
immunoreactivity to pre- and postsynaptic protein markers
is denoted by yellow puncta (spots of intense staining).
Each yellow punctum corresponded to the structural site of
a single functional synapse (Fig. 2a and b). At 17 DIV, the
clustering of both pre- and postsynaptic proteins was de-
creased with less co-localization of puncta observed in
Fmr1 KO neurons relative to their WTcounterparts (Fig. 2c,
p < 0.05). These results suggest that excitatory synapse for-
mation is altered in Fmr1 KO hippocampal neurons.
WT hippocampal neurons exhibit morphological spine
and synaptic deficits and when grown with an Fmr1 KO
astrocyte feeder layer
Membrane-bound factors are known participants in syn-
aptogenesis; however, the contributions of diffusible
astrocyte factors on neuronal development in FXS have
not been elucidated. To explore the possible role of dif-
fusible factors, we plated hippocampal neurons on glass
coverslips positioned below a feeder layer of astrocytes
(AFL), facilitating the exposure of soluble factors to neu-
rons through a membrane without direct contact be-
tween these two cell types (Fig. 3a). Using this non-
contact co-culture approach, we found that deficits in
FMRP in astrocytes affected the development of spines
at 17 DIV. Although no significant effects were observed
on spine density, we found that WT neurons exhibited
morphological deficits when grown in the presence of an
Fmr1 KO feeder layer. WT hippocampal neurons cul-
tured below an Fmr1 KO feeder layer displayed abnor-
mally longer spines (Fig. 3b, ~1.6 fold increase) than
WT neurons grown independently (Fig. 3c, p < 0.001) or
with a WT feeder layer (Fig. 3c, p < 0.001). In addition,
WT neurons exhibited a striking increase in the density
of immature filopodia-like spines (Fig. 3d, p < 0.001)
when cultured in combination with an Fmr1 KO feeder
layer. WT hippocampal neurons grown in the presence
of an Fmr1 KO feeder layer also presented with a reduced
proportion of stubby spines that are typically indicative of
mature spines (Fig. 3e, p < 0.001). Notably, WT neurons
supplemented with a feeder layer of normal astrocytes dis-
played the highest proportion of stubby spines, suggesting
that WT astrocytes promote spine maturation. Conversely,
the increased frequency of ‘immature’ thin spine pheno-
types, reminiscent of immature spine precursors, filopodia,
suggests that Fmr1 KO astrocytes alter the appropriate for-
mation of dendritic spines in WT neurons. Further, the
observed spine phenotypes in the WT neurons cultured
with the Fmr1 KO feeder layer resemble the structural def-
icits observed in Fmr1 KO neurons, demonstrating a role
for secreted signals on spine development.
Next, we sought to ascertain the ability of ACM or
astrocyte-feeding layers to induce the development of
synapses in neurons (Fig. 3f ). WT neurons grown in the
presence of an Fmr1 KO feeder layer displayed
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significantly reduced co-localization relative to WT neu-
rons cultured alone (p < 0.05) or with a WT AFL (p <
0.001). These results demonstrate that synaptic protein
clustering is impaired when WT neurons are grown with
a feeder layer derived from Fmr1 KO astrocytes.
Spine and synaptic protein abnormalities are prevented
in Fmr1 KO neurons by WT astrocyte conditioned media
or a WT feeder layer
Given that Fmr1 KO astrocytes impact the dendrite morph-
ology of cultured WT hippocampal neurons, we tested
whether secreted molecules from WTastrocytes are able to
prevent the abnormal spine development in Fmr1 KO hip-
pocampal neurons. We analyzed the structural morphology
of dendritic spines in Fmr1 KO neurons cultured with ei-
ther conditioned media or a feeder layer derived from WT
astrocytes. The application of ACM to cultures has been re-
ported to be equally effective in inducing synapses as a
feeder layer of astrocytes [32]. Synaptogenic factors are
constitutively released from astrocytes grown in isolation in
culture and do not require a neuronal signal to stimulate
release [33, 34]. Our results showed that Fmr1 KO neurons
displayed an overall increase in spine length (Fig. 4a) com-
pared to Fmr1 KO neurons cultured with WT ACM (p <
Fig. 1 Spine length is altered in Fmr1 KO hippocampal neurons at 17 DIV. a Representative images of DiI labeled WT (left panel) and Fmr1 KO
(right panel) neurons highlighting dendrites and spines. Inset is an example of a 50 μm segment used for morphological analysis and quantification.
Note the high prevalence of filopodium-like spines in the Fmr1 KO dendritic segment (right panel) relative to the WT segment (left panel). b Cumulative
frequency distribution of spine lengths comparing Fmr1 KO and WT neurons. c Fmr1 KO neurons display increased dendritic spine length compared to
their WT counterparts. d Assessment of spine morphology in Fmr1 KO neurons shows a significant increase in the number of filopodia-like spines and
e a reduction in the number of stubby spines. Data was analyzed by Student’s t-test. Data are presented as the mean ± SEM, *p < 0.05, **p < 0.01; n = 75
neurons per group, N = 3 independent experiments. Scale bars: 10 μm
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0.05) or a WT feeder layer (p < 0.05). Remarkably, aberra-
tions in spine length were mitigated in the Fmr1 KO neu-
rons when supplemented with either WT ACM by −1.2
fold (Fig. 4b, p < 0.05) or a WT feeder layer by −1.4 fold
(Fig. 4b, p < 0.01). Furthermore, WT ACM significantly re-
duced the frequency of immature-appearing spine pheno-
types in the Fmr1 KO neurons (Fig. 4c, p < 0.01), restoring
the density of unstable spines to normal levels. Similarly, a
WT feeder layer considerably decreased the number of
filopodia-like spines (p < 0.05). WT ACM also promoted
spine maturation by inducing the formation of stubby/
mushroom spines in the Fmr1 KO neurons following
2.5 weeks in culture (Fig. 4d, p < 0.05). Likewise, Fmr1 KO
neurons grown with a WT feeder layer significantly in-
creased the density of stubby spines (p < 0.01). Together,
these results suggest that astrocyte-mediated signaling is an
important regulator of spine development and is sufficient
to rescue deficits in neuronal connections associated with
FXS.
Next, given that soluble factors derived from FMRP-
deficient astrocytes affect excitatory synapse formation,
we investigated whether normal astrocytes could prevent
the alterations observed in Fmr1 KO neurons. Consistent
with previous studies showing that ACM induces synapse
formation [17], we found that the addition of WT ACM to
Fmr1 KO neurons significantly increased the number of
synaptophysin/PSD95 co-localized puncta per 50 μm
length of dendrite (Fig. 4e, p < 0.05). Our results also
showed that a greater number of synaptic contacts were
formed in Fmr1 KO neurons supplemented with a WT
feeder layer (p < 0.01). Together, these results demonstrate
that synaptic protein clustering in Fmr1 KO neurons can
be restored to normal levels in the presence of FMRP-
expressing astrocytes and further suggest a role for secreted
factors in regulating synaptic development.
Intracellular and extracellular TSP-1 expression levels are
decreased in Fmr1 KO astrocytes
TSP-1 is a matricellular protein synthesized and released by
astrocytes during early development of the nervous system
[35, 36]. TSP-1 promotes neurite outgrowth and survival
[37–39], neuronal migration [40] and synaptogenesis [17]
in vivo and in vitro. It participates in synaptic remodeling
following injury [41] and is required for synaptic and motor
Fig. 2 Quantification of excitatory synapse formation at 17 DIV. a Representative images of WT and Fmr1 KO neurons visualized using
immunofluorescence. Inset is an example of a 50 μm segment used for excitatory synapse quantification. b Excitatory synapses are
denoted by the arrows representing the co-localization of pre-(synaptophysin, SYN, 1:250, green) and post-synaptic (PSD-95, 1:200, red)
puncta (arrows). Synapses were identified using a custom written plug-in for ImageJ (https://imagej.nih.gov/ij/) – “Puncta Analyzer”. c At 17 DIV, Fmr1
KO neurons exhibit a reduction in the number of co-localized puncta relative to their WT counterparts. Data was analyzed by Student’s t-test. Data are
presented as the mean ± SEM, *p < 0.05; n = 75 neurons per group, N = 3 independent experiments
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recovery after stroke [42], suggesting that TSP-1 also partic-
ipates in neuronal plasticity. Since TSP-1 has been identi-
fied as a major contributor to astrocyte-regulated excitatory
synapse formation [17, 43], we determined if the expression
of TSP-1 was altered in FXS cortical astrocytes. Here, we
found relatively high levels of TSP-1 expression in cortical
astrocytes (Fig. 5a). However, quantification of TSP-1 pro-
tein levels by ELISA showed marked reductions in both cel-
lular lysates and conditioned media derived from Fmr1 KO
astrocytes. In fact, Fmr1 KO astrocytes express 5 % less cel-
lular TSP-1 compared to their WT counterparts (Fig. 5b:
49.98 ± 13.24 ng/ml; p < 0.05); and secrete 20 % less TSP-1
into the media relative to their WT counterparts (Fig. 5c:
208.12 ± 40.77 ng/ml; p < 0.05). These results demonstrate
that TSP-1 expression and release are both altered in Fmr1
KO astrocytes, suggesting that a lack of FMRP expression
prevents normal TSP-1 expression in cortical astrocytes
during development.
Addition of TSP-1 corrects abnormal dendritic spine
development and excitatory synapse formation in Fmr1
KO neurons
Given the disruption in TSP-1 expression in Fmr1 KO
astrocytes and the aberrant growth of neurons in the
Fig. 3 WT hippocampal neurons display morphological spine deficits when grown in the presence of an Fmr1 KO astrocyte feeder layer. a Schematic
illustrating the indirect astrocyte-neuron co-culture set-up. Astrocytes were grown in a cell culture insert with a permeable membrane facing the neurons
and sharing the same, defined medium. b Cumulative frequency distribution of spine lengths comparing WT neurons grown independently
and in co-culture with WT or Fmr1 KO astrocyte feeder layers (AFL) at 17 DIV. c WT hippocampal neurons grown without direct contact
with Fmr1 KO astrocytes present with longer spines. d Assessment of spine morphology in Fmr1 KO AFL/WT neuron co-cultures indicates
a significant increase in the density of filopodia-like spines and (e) a decreased density of stubby spines. Spine density represents the
average number of spines scored in a 10 μm dendritic segment. f Fmr1 KO AFL/WT neuron co-cultures exhibit a reduction in the number
of co-localized synaptic puncta relative to WT neurons cultured alone or with a WT AFL (p < 0.01). Excitatory synapses represent the average number of
co-localized puncta scored in a 50 μm dendritic segment. One-way ANOVA with Bonferroni correction was used to analyze the data. Data are presented
as the mean ± SEM, **p < 0.01, ***p < 0.001; n = 50 neurons per group, N = 2 independent experiments
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presence of these cells, we examined the effects of exogen-
ous TSP-1 on dendritic spine morphology in cultured hip-
pocampal neurons. Fmr1 KO hippocampal neurons were
treated with human recombinant (rTSP-1; dosage of
250 ng/ml) to stimulate spine formation [27]. Treatment
with TSP-1 was well tolerated by the hippocampal neu-
rons, with no neurotoxicity at concentrations as high as
1000 ng/ml. Interestingly, the addition of rTSP-1 to Fmr1
KO neurons mimicked the restorative effects of a WT
feeder layer or WT ACM. Prior to rTSP-1 treatment, an
increased frequency of long, thin spines were observed in
Fmr1 KO neurons (Fig. 6a and b, p < 0.01). Following
TSP-1 treatment, spine protrusion length was significantly
reduced by 50 % in Fmr1 KO neurons (Fig. 6b, p < 0.001).
Treatment with rTSP-1 decreased the proportion of thin
spines (Fig. 6c, p < 0.05) and promoted the formation of
mature spines in 2.5 week-old cultures (Fig. 6d, p < 0.05).
To test whether the reduction in astrocytic TSP-1 was in-
deed responsible for the aberrant spine morphology, cul-
tured neurons were treated with either heat inactivated
TSP-1 (TSP1-HI) or rTSP-1 co-incubated with gabapentin
(GBP), a competitive TSP-1 receptor antagonist. Notably,
morphological spine anomalies were not corrected in
Fmr1 KO neurons treated with TSP1-HI or rTSP-1
Fig. 4 Morphological abnormalities in Fmr1 KO hippocampal neurons are corrected by WT astrocytes with indirect co-culture. a Cumulative frequency
distribution of spine lengths comparing Fmr1 KO neurons grown in the presence of a WT AFL or supplemented with WT ACM at 17 DIV. b Spine
length is significantly reduced in Fmr1 KO neurons cultured with WT ACM or WT AFL. c Co-cultures with WT AFL or WT ACM reduced the proportion
of immature spine phenotypes in the Fmr1 KO neurons. d Alternatively, WT ACM and WT AFL induced an increase in the formation of mature spines.
e Fmr1 KO neurons supplemented with WT ACM increases the co-localization of excitatory pre- and postsynaptic proteins, synaptophysin and PSD-95.
Similarly, WT AFL/Fmr1 KO neuron co-cultures enhance the number of co-localized puncta. One-way ANOVA with Bonferroni correction was used to
analyze the data. Data are presented as the mean ± SEM, *p < 0.05, **p < 0.01; n = 50 neurons, N = 2 independent experiments
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(250 ng/ml) with gabapentin (GBP; 32 ug), further con-
firming the specific role of active TSP-1 on Fmr1 KO hip-
pocampal neurons.
To elucidate the neuromodulary effects of TSP-1 on ex-
citatory synapse formation, Fmr1 KO neurons were treated
with a dose of 250 ng/ml of rTSP-1. At 17 DIV, an increase
in the co-localization of pre-and post-synaptic puncta was
observed when Fmr1 KO neurons were treated with rTSP-
1 (Fig. 6f and g; p < 0.001). Therefore, these results support
the concept that rTSP-1 can increase the number of both
presynaptic and postsynaptic protein clusters, contributing
to the recovery of the alterations in excitatory synapses in
Fmr1 KO neurons.
Discussion
Dendritic spine abnormalities have long been recognized
as structural correlates of learning impairments in FXS
and various forms of ASDs [44, 45]. However, the origin
and mechanisms involved in spine dysgenesis are not
well understood. In contrast to the expression of FMRP
in neurons, relatively little is known about the function
of FMRP in glial cells during CNS development. In these
particular experiments, we investigated the role of astro-
cytes in the development of the abnormal dendritic
spine morphology and synaptic aberrations seen in FXS.
Primary hippocampal neurons were grown in a non-
contact co-culture set-up with astrocytes for 17 DIV,
allowing for the continuous exchange of molecules be-
tween both cell types via the shared defined medium. In
this setting, we focused on the contribution of secreted
CNS matricellular molecules to neuronal development
and synapse formation using an Fmr1 knockout (KO)
Fragile X mouse model. Here, we show that: i) Fmr1 KO
astrocytes display deficits in TSP-1 levels; ii) An altered
Fig. 5 Reduced TSP-1 levels in cultured FXS cortical astrocytes. a Representative staining of cultured cortical astrocytes co-labeled with GFAP and
TSP-1. At 7 DIV, the cells were fluorescently labeled with anti-GFAP (glial fibrillary acidic protein, green) to visualize astrocytes and anti-TSP-1
(thrombospondin-1, red) to identify the intracellular expression of TSP-1 using a 20× objective. Nuclei were counterstained with DAPI (blue).
Cultured cortical astrocytes express abundant levels of TSP-1 at 7 DIV. Scale bars: 50 μm. b Quantification of intracellular TSP-1 protein levels by ELISA in
cellular lysates. Fmr1 KO astrocytes express lower levels of cellular TSP-1 compared to their WT counterparts. c Quantification of extracellular secreted TSP-
1 in astrocyte-conditioned media. Measurements in TSP-1 protein levels in ACM revealed marked reductions in secreted TSP-1 by Fmr1 KO astrocytes.
Data was analyzed by Student’s t-test. Data are presented as the mean ± SEM, *p < 0.05; n= 5 cultures per genotype
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expression of astrocyte-secreted factors plays a signifi-
cant role in dendritic spine dysgenesis and excitatory
synapse formation; iii) Exogenous TSP-1 reverts Fmr1
KO astrocyte-mediated spine and synaptic alterations to
normal levels.
Role of astrocytes in fragile X neurobiology
Astrocytes are important regulators of neuronal growth
and maturation, and are key players in the abnormal neuro-
biology of a number of developmental disorders, including
FXS [27, 46, 47]. In cultured hippocampal neurons,
astrocytes have been shown to be a critical component for
appropriate dendritic spine morphology and the ability of
neurons to form synapses [48–51]. Several studies have re-
cently linked the absence of FMRP in astrocytes to abnor-
mal neuronal structure and function in FXS. Our previous
work showed that the loss of FMRP in astrocytes causes ab-
normal dendritic morphology, including aberrant dendritic
branching and dysfunctional synapse development [9, 10].
It has also been shown that the selective loss of FMRP from
astrocytes (but not neurons) leads to the reduced expres-
sion of the glutamate transporter GLT-1 (EAAT2) and
Fig. 6 TSP-1 prevents spine alterations in Fmr1 KO neurons. Analysis of the effects of TSP-1 administration on dendritic spine morphology in Fmr1
KO hippocampal neurons at 17 DIV. Continuous treatment with recombinant TSP-1 (250 ng/ml) averted the spine alterations in Fmr1 KO neuronal
cultures. a Cumulative frequency distribution of spine lengths. b rTSP-1 induced a significant reduction in spine length and (c) the density
of filopodia-like spines in the Fmr1 KO neurons. d A marked increase in the density of stubby spines was observed following the application of rTSP-1.
Heat-inactivated human recombinant TSP-1 (HI-TSP1) or gabapentin (GBP; 32 ug) in combination with rTSP-1 did not exert a neuroprotective effect on
spines. One-way ANOVA with Bonferroni correction was used to analyze the data. All data are expressed as mean ± SEM. *p < 0.05; n = 75 neurons per
group, N = 3 independent experiments. e Dendritic segments labeled with fluorescent DiI to illustrate typical spine morphologies found in Fmr1 KO
neurons and following treatment with exogenous TSP-1, GBP/TSP-1 or HI-TSP-1, respectively. Scale bars: 10 μm. f Excitatory synapse formation
is normalized in Fmr1 KO following rTSP-1 treatment. Data was analyzed by Student’s t-test. Data are presented as the mean ± SEM, ***p < 0.001; n = 75
neurons per group, N = 3 independent experiments. g Double immunofluorescence of dendritic segments with PSD-95 (red) and synaptophysin
(green) to identify excitatory synapses. Scale bars: 10 μm
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subsequent reduced glutamate uptake by these cells [52]. In
this study, we confirmed that synapse formation between
neurons is driven by factors released from astrocytes, and
astrocytes devoid of FMRP affect proper spine develop-
ment. More importantly, factors derived from normal as-
trocytes protect the loss of synapse formation, decrease the
density of immature spines, and promote mature spine for-
mation in Fmr1 KO neurons.
Under normal conditions, the release of soluble factors
from astrocytes guide neurite growth, synapse formation
and maturation [34, 53]. In FXS, dendritic contacts fail
to mature and the result is aberrant neural connectivity.
We hypothesized this was due to a deficit in astrocyte-
derived factors since Fmr1 KO astrocytes grown with
WT neurons lacking direct contact contributed to the
abnormal spine morphology, evidenced by a greater
number of longer, thinner spines. In support of this, a
recent study by Yang et al. [54] showed that elevated
levels of neurotrophin-3 in Fmr1 KO astrocytes partially
altered dendritic growth in neurons. Therefore, we
aimed to identify potential additional astrocyte-derived
soluble factors that contribute to the spine development
and maturation impairment in FXS. Our study revealed
that Fmr1 KO astrocytes show a notable deficit in the
expression of soluble factor TSP-1, resulting in dendritic
spine dysgenesis in Fmr1 KO neuronal cultures that can
be corrected with the exogenous addition of TSP-1.
Thromobspondin-1 contributes to astrocyte-regulated
synapse formation
TSPs have been previously identified as important CNS
synaptogenic molecules. TSP-1 and −2 are transynaptic or-
ganizers, highly expressed by immature astrocytes, which
strongly promote structural synapse formation [55]. In par-
ticular, they act as permissive switches that time CNS syn-
aptogenesis and enable neuronal molecules to assemble
into synapses within a specific window of CNS develop-
ment. This narrow developmental window typically
coincides with the initiation of nascent synaptic contacts
between dendrites and axons. Therefore, TSP-1 and −2
serve a transient function and are not required for mainten-
ance of synapses in the adult. Both in vitro and in vivo stud-
ies have demonstrated the capacity of TSPs to increase
synapse number, promote the localization of synaptic mole-
cules, and refine the pre- and postsynaptic alignment [17,
56]. Furthermore, TSP1/2-deficient mice display a signifi-
cant decrease in the frequency of excitatory synapses [17].
TSPs have also been shown to regulate presynaptic function
by limiting presynaptic release at glutamatergic synapses,
serving as a protective mechanism against excitotoxicity
[25]. Recently, two transmembrane molecules were uncov-
ered in mediating TSP-induced synaptogenesis. Firstly, neu-
roligin 1 interacts with TSP-1 and mediates the acceleration
of synaptogenesis in young hippocampal neurons [26].
Secondly, α2δ-1, a subunit of the L-type Ca2+ channel com-
plex (LTCC), was also identified as the postsynaptic recep-
tor of TSP in excitatory CNS neurons [24]. Interaction
between TSP and α2δ–1 sequentially recruits synaptic scaf-
folding molecules and initiates synapse formation [57]. Sev-
eral other known receptors for TSP include the CD47
integrin- associated protein (CD47/IAP), a variety of integ-
rins, and the low-density lipoprotein receptor-related pro-
tein LRP1; however, the role of each of these interacting
proteins have not been elucidated.
Deficits in TSP-1 affect synapse and dendritic spine
development
Our findings revealed a decrease in TSP-1 protein expres-
sion in cellular lysates and in astrocyte-conditioned media
from Fmr1 KO astrocytes, which suggests that the lack of
TSP-1 derived from FMRP-deficient astrocytes interferes
with proper spine development and synapse formation in
FXS. Likewise, deficits in TSP-1 expression in astrocytes
has also been implicated in Down Syndrome (DS) from hu-
man brain tissue samples and DS cultured astrocytes [27].
In a study by Jayakumar et al. [58], a shortage of astroglial-
derived TSP-1 contributed to synaptic dysfunction in hep-
atic encephalopathy, which was linked to a decrease in the
neuronal expression of synaptophysin, synaptostagmin, and
PSD-95, all of which are critically involved in maintaining
the integrity of glutamatergic synapses. In line with these
findings, we observed that a decrease in TSP-1 expression
resulted in the reduced co-localization of pre- and post-
synaptic synaptophysin and PSD-95 in Fmr1 KO neurons.
Spine morphology is linked to synapse function and
mushroom-shaped spines are considered to represent the
most mature and stable spine morphology [59, 60]. Several
categories of spines have been identified based on their
shape and size, including thin, stubby, cup, and mushroom-
shaped. Recent studies suggest that excitatory synapses are
a component of mushroom-shaped dendritic spines [61].
Thus, the increase in mushroom-shaped spines in response
to TSP-1 treatment is consistent with our findings that
TSP-1 stimulates the formation of excitatory synapses. In
our study, we also found that spine length, a measure of
synaptic immaturity, was increased in Fmr1 KO mice, sug-
gesting a delay in the development of spines. The preva-
lence of thin, elongated dendritic spine morphology in
Fmr1 KO mice is reminiscent of that observed during early
synaptogenesis [62] in the developing brain, as well as the
morphology seen following sensory deprivation [63, 64].
The increase in immature-appearing spines could be
due to augmented spine turnover [64], which fails to
decrease in the early postnatal weeks in FXS [5]. Alter-
natively, the abundance of immature-looking spines in
the Fmr1 KO mice could be caused by a failure of a
subset of spines to mature.
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Interestingly, significant differences in overall spine
density between the WT and Fmr1 KO neurons were not
observed. Similar studies in Fmr1 KO mice have also
found normal hippocampal spine densities [65] and indi-
vidual spines with longer lengths [66]. In contrast, others
have reported decreased spine density in the Fmr1 KO
mice compared to WT littermates [67, 68] and spines of
normal length [67]. However, the discrepancies are likely
attributed to the use of different staining and quantifica-
tion methods of spines, and the choice of tissue source
(cultured hippocampal neurons versus in vivo or ex vivo
brain tissue). As we observed for hippocampal neurons,
Braun et al. [62] also reported a lower abundance of exci-
tatory synapses in Fmr1 KO hippocampal neurons relative
to WT at 2 weeks in culture. The failure of excitatory syn-
apse maturation has also been noted in cortical neurons
of Fmr1 KO mice [69–71], as well as in Fmr1 KO cerebel-
lar granule cells [72].
Severe learning deficits have been associated with synap-
tic dysfunction in FXS and intellectual disabilities [73–75].
Here, we showed that deficits in the formation of dendritic
spines in Fmr1 KO neurons could be normalized with
conditioned media or a feeder layer derived from normal
astrocytes. Similarly, we demonstrated that the addition of
exogenous TSP-1 to neuronal cultures markedly promoted
the formation of mature (mushroom-shaped) dendritic
spines and restored the number of synaptic protein clus-
ters in Fmr1 KO neurons comparable to the level that of
WT neurons at 17 DIV. Notably, the application of ACM
+TSP-1 has been shown to increase synaptic puncta to
the same extent as either ACM or TSP-1 alone, indicating
that TSP-1 alone is sufficient to recover synapse formation
[17]. Mechanistically, TSP-1 may exert its restoring role in
Fmr1 KO neurons by specifically counteracting the loss in
FMRP on the dendritic spines that are immature as a re-
sult of FMRP loss. Therefore, these findings identify TSP-1
as a critical astrocyte-secreted factor that modulates spine
morphology and provide evidence that astrocytes are im-
portant contributors to synaptogenesis within the develop-
ing CNS. As such, defects in the secretion of astrocyte-
derived TSP-1 during a crucial window of development
likely contribute to the abnormal neurobiology seen in
FXS. The potential therapeutic role of TSP molecules in
excitatory synaptogenesis and their relevance to learning
and memory in FXS will be an exciting avenue of future
investigation.
Correspondingly, these findings highlight the import-
ant role of FMRP in astrocytes during the early postnatal
weeks of synaptic development in FXS. However, the full
extent of the cellular and molecular interactions that
govern non-contact-mediated synaptogenic signaling be-
tween astrocytes and neurons is not clear. For instance,
WT neurons cultured with an astrocyte feeder layer de-
rived from Fmr1 KO mice exhibit fewer mature spines
than WT neurons cultured alone. These results suggest
that Fmr1 KO astrocytes may potentially release inhibi-
tory substances that prevent normal spine development.
Given that profound changes in both excitatory and in-
hibitory neurotransmission have been reported in FXS
[76], the mechanisms involving a lack of factor and/or
the exertion of inhibitory effects warrant further investi-
gation. Therefore, studies exploring the contributions of
additional factors may provide greater insight into the
underlying mechanisms of FXS.
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